TSO3 Releases Q2 Financial Results

TSO3 (TSX:TOS) released their financial results for the second quarter of 2017.

As quoted in the press release:

Management Commentary

“We are pleased with our continued operating performance in the second quarter of 2017 as we supported Getinge to market and sell our STERIZONE® VP4 Sterilizers in hospitals in North America and Europe,” stated R. M. (Ric) Rumble, TSO3‘s President and CEO.  “We made significant progress during the quarter toward our duodenoscope regulatory claim strategy, enhancing our products and improving our production and service methods.  We are looking forward to the months to come.”

Click here to read the full press release.

Get the Latest Medical Device Investing Stock Information

Get the latest information about companies associated with Medical Device Investing delivered directly to your inbox.

Medical Device

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time.


Leave a Reply